JP2016502843A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502843A5
JP2016502843A5 JP2015547559A JP2015547559A JP2016502843A5 JP 2016502843 A5 JP2016502843 A5 JP 2016502843A5 JP 2015547559 A JP2015547559 A JP 2015547559A JP 2015547559 A JP2015547559 A JP 2015547559A JP 2016502843 A5 JP2016502843 A5 JP 2016502843A5
Authority
JP
Japan
Prior art keywords
bioactive agent
capture
cell
solid surface
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015547559A
Other languages
English (en)
Japanese (ja)
Other versions
JP6484178B2 (ja
JP2016502843A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/074756 external-priority patent/WO2014093671A1/en
Publication of JP2016502843A publication Critical patent/JP2016502843A/ja
Publication of JP2016502843A5 publication Critical patent/JP2016502843A5/ja
Application granted granted Critical
Publication of JP6484178B2 publication Critical patent/JP6484178B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015547559A 2012-12-12 2013-12-12 生物活性剤の細胞標的の捕捉のための組成物および方法 Active JP6484178B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261736426P 2012-12-12 2012-12-12
US61/736,426 2012-12-12
US201361788313P 2013-03-15 2013-03-15
US61/788,313 2013-03-15
PCT/US2013/074756 WO2014093671A1 (en) 2012-12-12 2013-12-12 Compositions and methods for capture of cellular targets of bioactive agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019025449A Division JP6999589B2 (ja) 2012-12-12 2019-02-15 生物活性剤の細胞標的の捕捉のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2016502843A JP2016502843A (ja) 2016-02-01
JP2016502843A5 true JP2016502843A5 (enExample) 2019-02-07
JP6484178B2 JP6484178B2 (ja) 2019-03-13

Family

ID=50934961

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015547559A Active JP6484178B2 (ja) 2012-12-12 2013-12-12 生物活性剤の細胞標的の捕捉のための組成物および方法
JP2019025449A Active JP6999589B2 (ja) 2012-12-12 2019-02-15 生物活性剤の細胞標的の捕捉のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019025449A Active JP6999589B2 (ja) 2012-12-12 2019-02-15 生物活性剤の細胞標的の捕捉のための組成物および方法

Country Status (11)

Country Link
US (2) US9551705B2 (enExample)
EP (1) EP2931305B1 (enExample)
JP (2) JP6484178B2 (enExample)
KR (2) KR102227321B1 (enExample)
CN (1) CN104853767B (enExample)
AU (2) AU2013359160B2 (enExample)
BR (1) BR112015013715A2 (enExample)
CA (1) CA2894432C (enExample)
IL (1) IL239213B (enExample)
SG (1) SG11201504520XA (enExample)
WO (1) WO2014093671A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102652175B (zh) 2009-12-09 2016-02-10 宝洁公司 织物和家居护理产品
US9056885B2 (en) 2011-11-21 2015-06-16 Promega Corporation Carboxy X rhodamine analogs
CA2894432C (en) * 2012-12-12 2022-06-07 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
WO2014151282A1 (en) 2013-03-15 2014-09-25 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
EP3304078B1 (en) * 2015-06-05 2022-08-31 Promega Corporation Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
US10458988B2 (en) * 2017-03-03 2019-10-29 Musc Foundation For Research Development Biotinylated luminescent probe
US11709155B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US12180581B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709156B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved analytical analysis
US12181452B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
JP7584433B2 (ja) 2019-03-20 2024-11-15 プロメガ コーポレイション 光親和性プローブ
US11918936B2 (en) 2020-01-17 2024-03-05 Waters Technologies Corporation Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding
EP4217730B1 (en) 2020-09-24 2025-08-20 Waters Technologies Corporation Chromatographic hardware improvements for the separation of reactive molecules
JP2022182394A (ja) * 2021-05-28 2022-12-08 独立行政法人国立病院機構 抗原固相化デバイス
WO2023287984A1 (en) * 2021-07-14 2023-01-19 University Of Maryland, Baltimore Suberoylanilide hydroxamic acid (saha) drugs, conjugates, and nanoparticles, and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
ES2136103T3 (es) 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
JPH08502528A (ja) 1992-10-14 1996-03-19 スターリング ウィンスロップ アイエヌシー. キレート化ポリマー
US5756688A (en) 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
GB9503969D0 (en) 1995-02-28 1995-04-19 Sams Bernard Incrementing mechanism
US20020004202A1 (en) 2000-01-24 2002-01-10 Cornish Virginia W. In vivo screen using chemical inducers of dimerization
US20020168737A1 (en) 2001-01-24 2002-11-14 Cornish Virginia W. Binding and catalysis screen for high throughput determination of protein function using chemical inducers of dimerization
SI1545613T1 (sl) * 2002-07-31 2011-11-30 Seattle Genetics Inc Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
EP2341134B1 (en) 2003-01-31 2014-08-27 Promega Corporation Covalent tethering of functional groups to proteins
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
KR100507796B1 (ko) 2003-04-03 2005-08-17 한미약품 주식회사 생체내 반감기가 증가된 peg-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP1989548A2 (en) * 2006-02-08 2008-11-12 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules
JP5420198B2 (ja) * 2008-06-16 2014-02-19 オリンパス株式会社 タンパク質相互作用解析方法、ポリヌクレオチド、および、組成物
KR100891456B1 (ko) 2008-11-06 2009-04-01 씨지케이 주식회사 생리활성물질에 대한 세포내 표적물질을 검출하는 방법 및 장치
BRPI1010019B1 (pt) * 2009-05-01 2019-02-05 Promega Corp polipeptídeo de luciferase modificada, vetor e kit compreendendo os mesmos
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
CA2894432C (en) 2012-12-12 2022-06-07 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
WO2014151282A1 (en) * 2013-03-15 2014-09-25 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
EP3304078B1 (en) * 2015-06-05 2022-08-31 Promega Corporation Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements

Similar Documents

Publication Publication Date Title
JP2016502843A5 (enExample)
Breadmore et al. Recent advances in enhancing the sensitivity of electrophoresis and electrochromatography in capillaries and microchips (2014–2016)
Skaug et al. Intermittent molecular hopping at the solid-liquid interface
US20050239068A1 (en) Method for isolating nucleic acids and protein from a single sample
WO2017085172A3 (en) Improved serum albumin binders
BR112021012665A2 (pt) Polipeptídeos úteis para edição de genes e métodos de uso
JP2013255517A5 (enExample)
JP2007503831A5 (enExample)
JP2017536114A5 (enExample)
JP2014012025A5 (enExample)
WO2011123246A3 (en) Solid-phase clonal amplification and related methods
Bole et al. Advanced materials for the recognition and capture of whole cells and microorganisms
WO2011073214A3 (en) A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
WO2014106004A3 (en) High-throughput system and method for identifying antibodies having specific antigen binding activities
EA201892691A1 (ru) Однодоменный белок, связывающий сывороточный альбумин
JP5053089B2 (ja) 化合物の直接単離および多成分サンプルの分別のための磁性材料の使用
Podgornik et al. Application of monoliths for bioparticle isolation
JP2016531924A5 (enExample)
JP2014528696A5 (enExample)
JP2017514481A5 (enExample)
JP2017536846A5 (enExample)
WO2012091564A3 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding mhc-mage complex that induces apoptosis
WO2016048994A3 (en) Systems and methods of cell-free protein synthesis in droplets and other compartments
JP2016513643A5 (enExample)
Zeng et al. Efficient enrichment of phosphopeptides by magnetic TiO2‐coated carbon‐encapsulated iron nanoparticles